Sherif Eltawansy, Faizan Ahmed, Grishma Sharma, Pawel Lajczak, Ogechukwu Obi, Hardik A Valand, Bhavin Patel, Dawood Shehzad, Mohamed Abugrin, Anam Mubasher, Asjad Salman, Joseph Heaton, Jesus Almendral
{"title":"慢性阻塞性肺疾病负担对心房颤动患者的影响:一项全国性研究","authors":"Sherif Eltawansy, Faizan Ahmed, Grishma Sharma, Pawel Lajczak, Ogechukwu Obi, Hardik A Valand, Bhavin Patel, Dawood Shehzad, Mohamed Abugrin, Anam Mubasher, Asjad Salman, Joseph Heaton, Jesus Almendral","doi":"10.14740/jocmr6243","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) and atrial fibrillation (Afib) are frequently comorbid, with COPD patients exhibiting a higher risk of Afib-related hospitalizations. This study investigated the relationship between COPD and Afib, focusing on 30-day readmission rates and outcomes.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study using the Nationwide Readmissions Database (NRD) from 2016 to 2020. We included adult patients (≥ 18 years) with a primary diagnosis of Afib while excluding those with December discharges to ensure a complete 30-day follow-up. We compared patients with and without COPD, analyzing 30-day readmission rates, length of stay (LOS), hospital costs, in-hospital mortality, and associated factors using multivariable Cox and logistic regression models.</p><p><strong>Results: </strong>A total of 1,064,982 patients admitted with Afib were included, of which 873,070 had no COPD, and 191,912 had it. COPD patients were older (73.19 vs. 70.82 years), had a shorter LOS (coefficient = -0.05, P = 0.002, 95% confidence interval (CI): -0.08 to -0.02), and had a higher comorbidity burden (Elixhauser comorbidity index: 5.13 vs. 3.43, P < 0.0001). The 30-day readmission rate was significantly higher in the COPD group (16.0% vs. 9.0%, P < 0.001). Logistic regression revealed that COPD increased the odds of readmission (odds ratio: 1.35, 95% CI: 1.32 to 1.39, P < 0.001).</p><p><strong>Conclusion: </strong>COPD is a significant risk factor for 30-day readmission and in-hospital mortality among Afib patients, underscoring the need for integrated approaches targeting both diseases.</p>","PeriodicalId":94329,"journal":{"name":"Journal of clinical medicine research","volume":"17 6","pages":"309-319"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239842/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of Chronic Obstructive Pulmonary Disease Burden on Patients With Atrial Fibrillation: A Nationwide Study.\",\"authors\":\"Sherif Eltawansy, Faizan Ahmed, Grishma Sharma, Pawel Lajczak, Ogechukwu Obi, Hardik A Valand, Bhavin Patel, Dawood Shehzad, Mohamed Abugrin, Anam Mubasher, Asjad Salman, Joseph Heaton, Jesus Almendral\",\"doi\":\"10.14740/jocmr6243\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) and atrial fibrillation (Afib) are frequently comorbid, with COPD patients exhibiting a higher risk of Afib-related hospitalizations. This study investigated the relationship between COPD and Afib, focusing on 30-day readmission rates and outcomes.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study using the Nationwide Readmissions Database (NRD) from 2016 to 2020. We included adult patients (≥ 18 years) with a primary diagnosis of Afib while excluding those with December discharges to ensure a complete 30-day follow-up. We compared patients with and without COPD, analyzing 30-day readmission rates, length of stay (LOS), hospital costs, in-hospital mortality, and associated factors using multivariable Cox and logistic regression models.</p><p><strong>Results: </strong>A total of 1,064,982 patients admitted with Afib were included, of which 873,070 had no COPD, and 191,912 had it. COPD patients were older (73.19 vs. 70.82 years), had a shorter LOS (coefficient = -0.05, P = 0.002, 95% confidence interval (CI): -0.08 to -0.02), and had a higher comorbidity burden (Elixhauser comorbidity index: 5.13 vs. 3.43, P < 0.0001). The 30-day readmission rate was significantly higher in the COPD group (16.0% vs. 9.0%, P < 0.001). Logistic regression revealed that COPD increased the odds of readmission (odds ratio: 1.35, 95% CI: 1.32 to 1.39, P < 0.001).</p><p><strong>Conclusion: </strong>COPD is a significant risk factor for 30-day readmission and in-hospital mortality among Afib patients, underscoring the need for integrated approaches targeting both diseases.</p>\",\"PeriodicalId\":94329,\"journal\":{\"name\":\"Journal of clinical medicine research\",\"volume\":\"17 6\",\"pages\":\"309-319\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239842/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical medicine research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14740/jocmr6243\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical medicine research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/jocmr6243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:慢性阻塞性肺疾病(COPD)和心房颤动(Afib)经常是合并症,COPD患者表现出更高的心房颤动相关住院风险。本研究调查了COPD和Afib之间的关系,重点关注30天再入院率和结果。方法:我们利用2016年至2020年全国再入院数据库(NRD)进行了一项回顾性队列研究。我们纳入了初步诊断为Afib的成年患者(≥18岁),同时排除了12月出院的患者,以确保完整的30天随访。我们比较了有和没有COPD的患者,使用多变量Cox和logistic回归模型分析了30天再入院率、住院时间(LOS)、住院费用、住院死亡率和相关因素。结果:共纳入1,064,982例Afib患者,其中873,070例无COPD, 191,912例有COPD。COPD患者年龄较大(73.19 vs. 70.82岁),LOS较短(系数= -0.05,P = 0.002, 95%可信区间(CI): -0.08 ~ -0.02),合病负担较高(Elixhauser合病指数:5.13 vs. 3.43, P < 0.0001)。COPD组30天再入院率显著高于COPD组(16.0% vs. 9.0%, P < 0.001)。Logistic回归显示COPD增加了再入院的几率(优势比:1.35,95% CI: 1.32 ~ 1.39, P < 0.001)。结论:COPD是Afib患者30天再入院和住院死亡率的重要危险因素,强调需要针对这两种疾病的综合方法。
Impact of Chronic Obstructive Pulmonary Disease Burden on Patients With Atrial Fibrillation: A Nationwide Study.
Background: Chronic obstructive pulmonary disease (COPD) and atrial fibrillation (Afib) are frequently comorbid, with COPD patients exhibiting a higher risk of Afib-related hospitalizations. This study investigated the relationship between COPD and Afib, focusing on 30-day readmission rates and outcomes.
Methods: We conducted a retrospective cohort study using the Nationwide Readmissions Database (NRD) from 2016 to 2020. We included adult patients (≥ 18 years) with a primary diagnosis of Afib while excluding those with December discharges to ensure a complete 30-day follow-up. We compared patients with and without COPD, analyzing 30-day readmission rates, length of stay (LOS), hospital costs, in-hospital mortality, and associated factors using multivariable Cox and logistic regression models.
Results: A total of 1,064,982 patients admitted with Afib were included, of which 873,070 had no COPD, and 191,912 had it. COPD patients were older (73.19 vs. 70.82 years), had a shorter LOS (coefficient = -0.05, P = 0.002, 95% confidence interval (CI): -0.08 to -0.02), and had a higher comorbidity burden (Elixhauser comorbidity index: 5.13 vs. 3.43, P < 0.0001). The 30-day readmission rate was significantly higher in the COPD group (16.0% vs. 9.0%, P < 0.001). Logistic regression revealed that COPD increased the odds of readmission (odds ratio: 1.35, 95% CI: 1.32 to 1.39, P < 0.001).
Conclusion: COPD is a significant risk factor for 30-day readmission and in-hospital mortality among Afib patients, underscoring the need for integrated approaches targeting both diseases.